Clinical Trials Directory

Trials / Unknown

UnknownNCT06346561

The Efficacy of Dexmedetomidine Versus Labetalol In Providing Controlled Hypotension In Dacryocystorhinostomy SurgeryA Comparative Randomized Prospective Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The most important symptoms of nasolacrimal duct obstruction are excessive tearing and mucoid discharge. The proposed treatment in this regard is dacryocystorhinostomy (DCR) surgery. Therefore, hemostasis is of great significance in performing DCR surgery. In this regard, the reduction of controlled hypotension and the control of hemodynamic responses of the body to stress effectively reduce the bleeding volume during surgery. Hence, there is no enough studies about controlled hypotension in DCR we decided to perform such a comparison between the effect of dexmedetomidine and labetalol in providing controlled hypotension during DCR surgery.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidinethe reduction of controlled hypotension and the control of hemodynamic responses of the body
DRUGLabetalolthe reduction of controlled hypotension and the control of hemodynamic responses of the body

Timeline

Start date
2024-03-30
Primary completion
2024-08-30
Completion
2024-08-30
First posted
2024-04-04
Last updated
2024-04-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06346561. Inclusion in this directory is not an endorsement.